Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter Risk of sudden death and cardiac dysrhythmias in patients being treated with Norpramin.
Source: www.fda.govVoltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes Cases of drug-induced hepatotoxicity reported, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure.
Source: www.fda.govVIA Pharmaceuticals Completes Patient Visits In Phase 2 Trial Of VIA-2291VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced that it has completed the last patient visit in its Phase 2 FDG-PET clinical trial of VIA-2291...
Source: www.medicalnewstoday.comWhy Some Monkeys Don't Get AIDSTwo studies published this month in the Journal of Clinical Investigation provide a significant advance in understanding how some species of monkeys such as sooty mangabeys and African green monkeys avoid AIDS when infected with SIV, the simian equivalent of HIV...
Source: www.medicalnewstoday.comFDA Approves Lilly's Zyprexa For Two Adolescent IndicationsThe U.S. Food and Drug Administration (
FDA) approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old...
Source: www.medicalnewstoday.comCardiovascular Systems ViperSheath Sheath Introducer - Recall Nationwide recall due to stretching or fracture of the sheath during use.
Source: www.fda.govLexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter Potential association between Lexiva and myocardial infarction in HIV infected adults.
Source: www.fda.govGenzyme Products, Marketed as Cerezyme, Fabrayzme, Myozyme, Aldurazyme, and Thyrogen Foreign particle contamination of several products manufactured by Genzyme, which may lead to serious adverse events including damage to blood vessels or embolic events, and anaphylactic, allergic and immune-mediated reactions.
Source: www.fda.gov
# posted by Network @ 12:05 AM
